[1] Lu H, Dhanabal M, Volk R, et al. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells[J]. Binchem Biophys Res Commun, 1999, 258(3):668-673.
[2] Cai W, Ma J, Li C, et al. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization[J]. J Cell Biochem, 2005:96(6):1254-1261.
[3] Léger R, Benquet C, Huang X, et al. Kringle 5 peptide-albumin conjugates with anti-migratory activity[J]. Bioorg Med Chem Lett, 2004, 14(4):841-845.
[4] Nguyen TM, Subramanian IV, Kelekar A, et al. Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells[J]. Blood, 2007, 109(11):4793-4802.
[5] Wang H, Schultz R, Hong Y, et al. Cell surface-dependent generation of angiostatin4.5[J]. Cancer Res, 2004, 64(1):162-168.
[6] Griffioen AW, Molema G. Angiogenesis:potentials for pharmacologic interventioa in the treatment of cancer, cardiovascular diseases, and chronic inflammation[J]. Pharmacol Rev, 2000, 52(2):237-268.
[7] Wang H, Doll JA, Jiang K, et al. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin:implications for cancer-mediated angiogenesis[J]. Cancer Res, 2006, 66(14):7211-7215.
[8] Gonzalez-Gronow M, Kalfa T, Johnson CE, et al. The vohagedependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells[J]. J Biol Chem, 2003, 278(29):27312-27318.
[9] Gao G, Li Y, Gee S, et al. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor:a possible mechanism for the anti-angiogenic activity of plasminogen kringle5[J]. J Biol Chem, 2002, 277(11):9492-9497.
[10] Tarui T, Miles LA, Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3)in endothelial cells[J]. J Biol Chem, 2001,276(43):39562-39568.
[11] Davidson DJ, Haskell C, Majest S, et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78[J]. Cancer Res, 2005, 65(11):4663-4672.
[12] Yang X, Cheng R, Li C, et al. Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity[J]. Cancer Biol Ther, 2006, 5(4):399-405.
[13] Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents:exploring mechanisms of interaction[J]. Clin Cancer Res, 2003, 9(6):1957-1971.
[14] 李彪,赵龙,张一帆,等.重组人纤溶酶原Kringle5的标记及其肿瘤显像[J].上海第二医科大学学报,2005,25(12):1218-1220.
[15] 尹桂芝,李彪,张大东,等.重组人纤溶酶原Kringle 5的125I标记及其体内代谢[J].黑龙江医药科学,2007,30(1):51-53.